(–)‐(3a′S,4′S,9b′S,1R,2S,5R)‐4′‐Ethyl‐3a′,4′,5′,7′,8′,9b′‐hexahydro‐2‐isopropyl‐5‐methyl‐2′‐phenyl­spiro­[cyclo­hexane‐1,7′‐dioxino[3,2‐e]isoindole]‐1′,3′,9′‐trione

By  

Acta Crystallographica Section E, Vol. 61, Iss. 2, 2005-02 ,pp. : o290-o291

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐[(1S,2S,3R)‐2‐Bromo‐3‐(tert‐butyl­di­phenyl­silyl­oxy)‐1‐phenyl‐4‐(phenyl­sulfonyl)­butyl]‐4‐methyl­benzene­sulfon­amide

By  

Acta Crystallographica Section E, Vol. 60, Iss. 12, 2004-12 ,pp. : o2290-o2292

John Wiley & Sons Inc

Access to resources Recommend Favorite

(3R,4R)‐(–)‐3‐Hydroxy­methyl‐4‐phenyl‐2‐o‐toluoyl‐1,2,3,4‐tetra­hydro­isoquinoline

By  

Acta Crystallographica Section E, Vol. 62, Iss. 5, 2006-05 ,pp. : o1774-o1776

John Wiley & Sons Inc

Access to resources Recommend Favorite

(3S,4R)‐4‐[4‐(Benzyloxy)phenyl]‐3‐(4‐fluorophenyl)‐1‐[(S)‐1‐(4‐methoxyphenyl)ethyl]azetidin‐2‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 6, 2007-06 ,pp. : o2844-o2845

John Wiley & Sons Inc

Access to resources Recommend Favorite

2,5‐Anhydro‐N‐benzyl‐2‐C‐methyl‐d‐arabinona­mide [(2S,3R,4R)‐N‐benzyl‐3,4‐dihydr­oxy‐2‐methyl­tetra­hydro­furan‐2‐carboxamide]

By  

Acta Crystallographica Section E, Vol. 63, Iss. 2, 2007-02 ,pp. : o574-o576

John Wiley & Sons Inc

Access to resources Recommend Favorite